MUCORMYCOSIS
Clinical trials for MUCORMYCOSIS explained in plain language.
Never miss a new study
Get alerted when new MUCORMYCOSIS trials appear
Sign up with your email to follow new studies for MUCORMYCOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Cresemba under the microscope: Real-World safety check for fungal infections
Disease control CompletedThis study looked at how safe and effective the drug Cresemba (isavuconazole) is for Korean patients with serious fungal infections like invasive aspergillosis or mucormycosis. Researchers tracked side effects and how well the drug worked in 94 adults. The goal was to confirm the…
Matched conditions: MUCORMYCOSIS
Sponsor: Pfizer • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
COVID-19's hidden toll: fungal infections rise in transplant patients
Knowledge-focused CompletedThis study looked back at 60 adult blood cancer patients who had stem cell transplants and later developed a rare fungal infection called mucormycosis. Researchers compared cases before COVID-19 (2015-2020) to during the pandemic (2020-2024) to see if the virus, new tests, or new…
Matched conditions: MUCORMYCOSIS
Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:11 UTC
-
Real-World study examines Isavuconazole's effectiveness against deadly fungal infections
Knowledge-focused CompletedThis completed study looked at medical records of 307 adults in five European countries who were treated with the antifungal drug isavuconazole for serious fungal infections (invasive aspergillosis or mucormycosis). Researchers tracked how well the drug worked (clinical, radiolog…
Matched conditions: MUCORMYCOSIS
Sponsor: Pfizer • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:03 UTC